Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions

Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions

US Patent 8058264 · Granted Nov 15, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions containing ethylene polymers2019
Compositions containing ethylene polymers2018
Lipase variants for pharmaceutical use2017
Lipase variants for pharmaceutical use2015
Pharmaceutical compositions of lipase-containing products, in particular of panc2014
Protease variants for pharmaceutical use2013
Lipase variants for pharmaceutical use2012
N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and rela2010
N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and rela2010
N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and rela2010
N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and rela2010
1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products fo2010